PHIO — Phio Pharmaceuticals Corp.

PHIOPhio Pharmaceuticals Corp.

NAS · US · Healthcare · Biotechnology · phiopharma.com

1.120USD-0.45%Mkt Cap: 13.13M USDP/E: —Last update: 2026-06-01

Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expr…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap13.13M USD

Enterprise Value-4.14M USD

Revenue (TTM)—

Gross Profit-4.62M USD

Net Income (TTM)-8.70M USD

Revenue/Share—

Last Price1.120 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees6

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-1.29

PEG—

EV/EBITDA0.36

EV/Revenue—

P/S—

P/B0.78

EPS (TTM)-1.38

EPS (Forward)-0.86

52W Range

0.81309% of range4.190

52W High4.190 USD

52W Low0.8130 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-43.17%

ROA-40.48%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-7.98M USD

CapEx (TTM)12.00K USD

FCF Margin—

FCF Yield-55.26%

Net Debt-17.03M USD

Net Debt/EBITDA1.48

Balance Sheet

Debt/Equity—

Current Ratio18.32

Quick Ratio17.93

Book Value/Sh1.417 USD

Cash/Share1.466 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateJan 15, 2020

Splits

Last Split1:9

Split DateJul 5, 2024

Analyst Consensus

Rating—

Target (Mean)14.00 USD

Target Range14.00 USD – 14.00 USD

# Analysts1

Ownership

Shares Out.11.62M

Float11.55M

Insiders6.00%

Institutions10.82%

Short Interest

Short Ratio2.3d

Short % Float2.87%

Short % Out.2.85%

Shares Short331.57K

Short (prev mo.)520.52K

Technical

SMA 501.191 (-5.9%)

SMA 2001.473 (-24.0%)

Beta—

S&P 52W Chg27.70%

Avg Vol (30d)135.23K

Avg Vol (10d)118.84K

Technical Indicators

RSI (14)49.0

MACD-0.0242

MACD Signal-0.0312

MACD Hist.+0.0070

BB Upper1.165 USD

BB Middle1.106 USD

BB Lower1.046 USD

BB Width10.83%

ATR (14)0.0450 USD

Vol Ratio (20d)0.58x